Biolyse Pharma
Bolivia: Patients’ or patents’ rights in the times of the pandemic?
The Bolivian government reached an agreement with Biolyse, a Canadian drug manufacturer, to produce additional doses of COVID-19 vaccines if a compulsory license is issued. However, their efforts have been blocked by the interest of patent-holders profiteering on the pandemic.
- Google employees lead sit-ins protesting company’s complicity in genocide
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
